Endoscopy 2007; 39(7): 669-671
DOI: 10.1055/s-2007-966588
Case report

© Georg Thieme Verlag KG Stuttgart · New York

Multimodality treatments for nodal relapse after endoscopic mucosal resection of a superficial esophageal squamous cell carcinoma

K.  Fu1, 2 , T.  Ishikawa2 , H.  Ooyanagi2 , Y.  Kaji1 , H.  Shimizu3
  • 1Department of Radiology, Dokkyo Medical University, Mibu, Shimotuga, Tochigi, Japan
  • 2Department of Diagnostic Imaging, Division of Endoscopy, Tochigi Cancer Center Hospital, Utsunomiya, Tochigi, Japan
  • 3Department of Surgery, Tochigi Cancer Center Hospital, Utsunomiya, Tochigi, Japan
Further Information

Publication History

submitted 2 February 2007

accepted after revision 5 February 2007

Publication Date:
05 July 2007 (online)

Patients with esophageal intraepithelial carcinoma (m1) and carcinoma invading the lamina propria (m2) are generally considered good candidates for endoscopic mucosal resection (EMR) in Japan, as hardly any of them show lymph node metastasis. Although a few cases of esophageal carcinoma invading the lamina propria have been reported to show nodal involvement, lymph node metastasis and subsequent death due to carcinoma after EMR of m1 or m2 esophageal carcinoma has never been reported in the English literature. Here we describe a patient who suffered relapse of lymph node metastasis after EMR of an esophageal carcinoma invading the lamina propria without any of the reported risk factors associated with lymph node metastasis, including vascular invasion. Unfortunately, the patient died due to disease recurrence, despite receiving multimodality treatments including chemoradiotherapy and salvage surgery.

References

  • 1 Kodama M, Kakegawa T. Treatment of superficial carcinoma of the esophagus: a summary of responses to a questionnaire on superficial carcinoma of the esophagus in Japan.  Surgery. 1998;  123 432-439
  • 2 Tajima Y, Nakanishi Y, Ochiai A. et al . Histopathologic findings predicting lymph node metastasis and prognosis of patients with superficial esophageal carcinoma: analysis of 240 surgically resected tumors.  Carcinoma. 2000;  88 1285-1293
  • 3 Eguchi T, Nakanishi Y, Shimoda T. et al . Histopathological criteria for additional treatment after endoscopic mucosal resection for esophageal carcinoma: analysis of 464 surgically resected cases.  Mod Pathol. 2006;  19 475-480
  • 4 Japanese Society for Esophageal Disease .Guidelines for clinical and pathologic studies on carcinoma of the esophagus [in Japanese]. 9th edn. Tokyo; Kanehara Shuppan 1999
  • 5 Makuuchi H, Yoshida T, Ell C. Four-step endoscopic esophageal mucosal resection (EEMR) tube method of resection for early esophageal carcinoma.  Endoscopy. 2004;  36 1013-1018
  • 6 Makuuchi H. Endoscopic mucosal resection for mucosal carcinoma in the esophagus.  Gastrointest Endosc Clin North Am. 2001;  11 445-458
  • 7 Yamashita H, Nakagawa K, Tago M. et al . Salvage radiotherapy for postoperative loco-regional recurrence of esophageal carcinoma.  Dis Esophagus. 2005;  18 215-220
  • 8 Ohtsu A. Chemoradiotherapy for esophageal carcinoma: current status and perspectives.  Int J Clin Oncol. 2004;  9 444-450
  • 9 Swisher S G, Wynn P, Putnam J B. et al . Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy.  J Thorac Cardiovasc Surg. 2002;  123 175-183
  • 10 Nakamura T, Hayashi K, Ota M. et al . Salvage esophagectomy after definitive chemotherapy and radiotherapy for advanced esophageal carcinoma.  Am J Surg. 2004;  188 261-266

K. Fu, MD, PhD

Department of Radiology

Dokkyo Medical University

880 Kitakobaysashi

Mibu, Shimotuga

Tochigi 321-0293

Japan

Fax: +81-282-86-5678

Email: fukuangi@hotmail.com